Why are recombinant antibodies important in flow cytometry? 

Researchers and opinion leaders have considered a number of potential solutions to the so-called antibody-related reproducibility “crisis”. One is to transition from traditional monoclonal antibodies to recombinant antibodies*. 

So, what makes recombinant antibodies better and more effective than conventional hybridoma-derived antibodies?

We asked six experts from the flow cytometry and antibody community to share their opinion and experience with recombinant antibodies.  


Recombinant antibodies in flow cytometry – Six experts share their perspectives

Andrew Bradbury, Ph.D. 
Karl Johan Malmberg, M.D., Ph.D.
James Hutchinson, MB BChir, Ph.D. 
Anis Larbi, Ph.D.
Dr. Susanne Heck
Joffrey de la Larichaudy, Ph.D.